Profile
In the 20th century, we learned that healthy lifespan is malleable. The scientific pathways behind this effect are incredibly complex and difficult to correctly control, but manipulating them may lead to new treatments for age-related disease. We want to get these therapeutic advances translated safely to patients as quickly as possible. Longevity Fund companies have collected >$500M in follow-on funding, resulting in the 2018 IPO of the first company dedicated to reversing the diseases of aging, and multiple programs in clinic to reverse or prevent age-related disease.
Industry
Region of investment
Contacts
Upgrade to see contacts
Name
Title
Email
Social Networks
If there are no contacts of this investor, please write to us, we will try to find them as
soon as possible and get back
to you!
FAQs about The Longevity Fund
Where is The Longevity Fund located?
The Longevity Fund is located in United States.
When was The Longevity Fund founded?
The Longevity Fund was founded in 2011.
What sectors and industries does The Longevity Fund invest in?
The Longevity Fund invests in companies and startups in Biotechnology, Financial Services, Healthcare Services.
What is The Longevity Fund geographical focus of investments?
The Longevity Fund invests in companies and startups in North America.
At what stages of companies and startups does The Longevity Fund typically invest in?
The Longevity Fund invests in companies and startups at Seed.
What is the usual amount of The Longevity Fund investment?
The Longevity Fund usually invests $1-5 m on average.
What is the amount of assets of under management (AUM) for The Longevity Fund?
The Longevity Fund has around $37m assets under management.